Oakley Capital Invests in ProductLife Group

May 28, 2024

Oakley Capital Fund V is investing in ProductLife Group, a European provider of outsourced development, regulatory and compliance services to the life sciences industry. Oakley will partner with management and reinvesting shareholder 21 Invest to support international expansion, accelerate AI-driven technology enablement, and pursue a buy-and-build strategy.

Buyers
Oakley Capital (Oakley Capital Fund V)
Targets
ProductLife Group
Sellers
21 Invest
Industry
Pharmaceuticals
Location
Île-de-France, France
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.